Appleby acted as Cayman Islands counsel for Lichen China Limited (“Lichen China” or the “Company”, together with its subsidiaries, the “Group”) on the filing by the Company of a registration statement on Form F-3, on 21 February 2024 with the U.S. Securities and Exchange Commission under the U.S. Securities Act of 1933, for issue and sale from time to time by the Company of up to USD100,000,000 of securities.
The securities include ordinary shares, share purchase contracts, share purchase units, warrants, debt securities, rights and units. Lichen China intends to apply the net proceeds from the offering to contribute to their working capital and general corporate matters, and the amounts and timing of the use of proceeds will vary depending on a number of factors, including the amount of cash generated or used by the Company’s operations, and the rate of growth.
The Appleby team was led by Partner Judy Lee.
The Group is one of the leading financial and taxation service providers in China. It also offers educational support, and software and maintenance services in the PRC.
Our Hong Kong Capital Markets team is highly regarded for their extensive expertise in supporting offshore companies with IPOs, introductions, placements and listings of both equity and debt securities on the Hong Kong, US, Singapore and many other internationally recognised stock exchanges.
